浙江省新生儿多酰基辅酶<strong>A</strong>脱氢酶缺乏症筛查及随访分析

doi:10.3724/zdxbyxb-2021-0261

浙江大学学报（医学版）

2021, Vol. 50

Issue (4): 454-462 DOI: 10.3724/zdxbyxb-2021-0261

专题报道

浙江省新生儿多酰基辅酶A脱氢酶缺乏症筛查及随访分析

周朵¹(

),叶梅玲²,胡真真¹,张玉³,朱琳³,杨茹莱¹,黄新文^1,*(

)

1.浙江大学医学院附属儿童医院遗传与代谢科国家儿童健康与疾病临床医学研究中心国家儿童区域医疗中心，浙江杭州 310052
2.浙江省台州医院台州恩泽医疗中心（集团），浙江台州 317000
3.浙江博圣生物技术股份有限公司，浙江杭州 310012

Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients

ZHOU Duo¹(

),YE Meiling²,HU Zhenzhen¹,ZHANG Yu³,ZHU Lin³,YANG Rulai¹,HUANG Xinwen^1,*(

)

1. Department of Genetics and Metabolism, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children’s Regional Medical Center, Hangzhou 310052, China;
2. Taizhou Hospital of Zhejiang Province, Taizhou Enze Medical Center (Group), Taizhou 317000, Zhejiang Province, China;
3. Zhejiang Biosan Biochemical Technology Co., Ltd., Hangzhou 310012, China

全文: PDF(2346 KB)

HTML( 10 )

摘要：

目的：了解浙江省新生儿多酰基辅酶A脱氢酶缺乏症（MADD）的发病率、临床特征及基因突变特点。方法：采用串联质谱法对2009年1月至2020年12月浙江省新生儿疾病筛查中心3?896?789名新生儿进行遗传代谢病筛查，结合尿有机酸分析及电子转移黄素蛋白（ETF）或电子转移黄素蛋白脱氢酶（ETFDH）基因检测确诊。确诊患儿进行饮食和生活管理，补充左卡尼汀、核黄素、辅酶Q10治疗，长期随访并评估患儿的生长和智力发育情况。结果：确诊MADD患儿13例，除1例为Ⅱ型，其余均为Ⅲ型（迟发型），发病率为1/299?753。13例患儿中，1例死亡，4例因感染诱发以低血糖为主要表现的急性代谢失调，1例出现肌张力降低，其余患儿随访发育良好（随访时间3~45个月）。患儿初筛血C4~C18:1不同程度升高。13例患儿进行基因检测，其中ETFA基因复合杂合突变1例，ETFA基因纯合突变1例，ETFB基因复合杂合突变1例，ETFDH基因复合杂合突变8例，ETFDH基因纯合突变1例，仅检测出一个ETFDH基因突变位点1例。c.250G>A为热点突变。结论：MADD临床表现高度异质，新生儿期发病较为严重，迟发型常无明显临床症状，初筛血C4~C18:1不同程度升高，最常见基因突变为c.250G>A。

关键词： 新生儿筛查; 多酰基辅酶A脱氢酶缺乏症; 电子转移黄素蛋白; 电子转移黄素蛋白脱氢酶; 串联质谱法

Abstract:

Objective:To investigate the incidence rate, clinical and gene mutation characteristics of multiple acyl-CoA dehydrogenase deficiency (MADD) in newborns in Zhejiang province. Methods:A total of 3 896 789 newborns were screened for MADD using tandem mass spectrometry in Zhejiang Neonatal Screening Center during January 2009 and December 2020. Patients of MADD were confirmed by urine organic acid and electron transferring flavoprotein (ETF)or electron transferring flavoprotein dehydrogenase (ETFDH) gene detection. MADD patients were given diet and life management, supplemented with L-carnitine, riboflavin and coenzyme Q 10 treatment, and their growth and intellectual development were evaluated during the followed up.Results:Thirteen patients with MADD were diagnosed, with an incidence of 1/299 753. One patient was type Ⅱ, and the rest were type Ⅲ. Patients were followed up for 3–45?months, 1 case died, 4 cases had acute metabolic disorders with hypoglycemia as the main manifestation due to infection, 1 case had hypotonia, and the rest 7 cases developed well. Patients had raised levels of C4–C18:1 acylcarnitines in the initial screening. Thirteen children were genetically tested, 1 case with compound heterozygous mutation in the ETFA gene, 1 case with homozygous mutation in theETFA gene, 1 case with compound heterozygous mutation in the ETFB gene, 8 cases with compound heterozygous mutation and 1 case with homozygous mutation in the ETFDH gene, 1 case that only 1 locus of ETFDH gene was detected. The c.250G>A was the hotspot mutation in this study.Conclusion:The clinical manifestations of MADD are highly heterogeneous. The neonatal-onset form is serious, and late onset form usually has no obvious clinical symptoms. C4–C18:1 acylcarnitines usually increased in the initial screening, and the hotspot gene mutation is c.250G>A.

Key words: Neonatal screening Multiple acyl-CoA dehydrogenase deficiency Electron transferring flavoprotein Electron transferring flavoprotein dehydrogenase Tandem mass spectrometry

收稿日期: 2021-04-10 出版日期: 2021-11-01

CLC:

R722.11

基金资助: 国家重点研发计划（2018YFC1002204）；国家自然科学基金（82073560）；浙江省公益技术研究计划（LGC19B050013）

通讯作者: 黄新文 E-mail: 11318120@zju.edu.cn;6305022@zju.edu.cn

作者简介: 周　朵，主治医师，主要从事儿童遗传代谢病筛查和诊治工作；E-mail：11318120@zju.edu.cn；https：//orcid.org/0000-0002-6545-5351

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	周朵
	叶梅玲
	胡真真
	张玉
	朱琳
	杨茹莱
	黄新文

引用本文:

周朵,叶梅玲,胡真真,张玉,朱琳,杨茹莱,黄新文. 浙江省新生儿多酰基辅酶A脱氢酶缺乏症筛查及随访分析[J]. 浙江大学学报（医学版）, 2021, 50(4): 454-462.

ZHOU Duo,YE Meiling,HU Zhenzhen,ZHANG Yu,ZHU Lin,YANG Rulai,HUANG Xinwen. Screening of multiple acyl-CoA dehydrogenase deficiency in newborns and follow-up of patients. J Zhejiang Univ (Med Sci), 2021, 50(4): 454-462.

链接本文:

http://www.zjujournals.com/med/CN/10.3724/zdxbyxb-2021-0261 或 http://www.zjujournals.com/med/CN/Y2021/V50/I4/454

表 1 13例多酰基辅酶A脱氢酶缺乏症确诊患儿实验室和影像学检查结果

表 2 13例多酰基辅酶A脱氢酶缺乏症确诊患儿血酰基肉碱水平

表 3 13例多种酰基辅酶A脱氢酶缺乏症确诊患儿基因突变检测结果

1	OLSENR K J, OLPINS E, ANDRESENB S, et al.ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency[J]Brain, 2007, 130( 8): 2045-2054. doi: 10.1093/brain/awm135
2	CHENW, ZHANGY, NIY, et al.Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations[J]BMC Neurol, 2019, 19( 1): 330. doi: 10.1186/s12883-019-1562-5
3	HUX M, LIL. Multiple Acyl-CoA dehydrogenase deficiency in an infant[J]Ind J Pediatr, 2019, 86( 2): 194-195. doi: 10.1007/s12098-018-2768-z
4	MACCHIONEF, SALVIATIL, BORDUGOA, et al.Multiple acyl-COA dehydrogenase deficiency in elderly carriers[J]J Neurol, 2020, 267( 5): 1414-1419. doi: 10.1007/s00415-020-09729-z
5	YAMADAK, KOBAYASHIH, BOR, et al.Efficacy of bezafibrate on fibroblasts of glutaric acidemia type Ⅱ patients evaluated using an in vitro probe acylcarnitineassay[J]Brain Dev, 2017, 39( 1): 48-57. doi: 10.1016/j.braindev.2016.08.004
6	YAMADAK, KOBAYASHIH, BOR, et al.Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type Ⅱ: Characteristics in comparison with pediatric cases[J]Brain Dev, 2016, 38( 3): 293-301. doi: 10.1016/j.braindev.2015.08.011
7	HONGD J, ZHUM, ZHUZ J, et al.Clinical and muscle magnetic resonance image findings in patients with late-onset multiple acyl-CoA dehydrogenase deficiency[J]Chin Med J, 2019, 132( 3): 275-284. doi: 10.1097/CM9.0000000000000032
8	PANX Q, CHANGX L, ZHANGW, et al.Late-onset multiple acyl-CoA dehydrogenase deficiency with cardiac syncope: a case report[J]World J Clin Cases, 2020, 8( 5): 995-1001. doi: 10.12998/wjcc.v8.i5.995
10	丰利芳，陈晓红，李东晓，等. 上呼吸道感染患儿口服尼美舒利后发生瑞氏综合征及猝死样症状[J]. 中国当代儿科杂志， 2018, 20（11）： 944-949 FENG Lifang, CHEN Xiaohong, LI Dongxiao, et al. Reye syndrome and sudden death symptoms after oral administration of nimesulide due to upper respiratory tract infection in a boy[J]. Chinese Journal of Contemporary Pediatrics, 2018, 20（11）： 944-949. （in Chinese）
10	陆　妹，杨艳玲. 线粒体脂肪酸氧化代谢病与猝死[J]. 中国实用儿科杂志, 2019, 34(7): 551-555 LU Mei, YANG Yanling. Mitochondrial fatty acid β-oxidation disorders and sudden death[J]. Chinese Journal of Practical Pediatrics, 2019, 34(7): 551-555. （in Chinese）
11	郑　静, 赵正言, 黄新文, 等. 浙江省新生儿脂肪酸氧化代谢筛查及随访分析[J].浙江大学学报(医学版), 2017, 46(3): 248-255 ZHENG Jing, ZHAO Zhengyan, HUANG Xinwen, et al. Screening forfatty acid oxidation disorders of newborns in Zhejiang province: prevalence, outcome and follow-up[J]. Journal of Zhejiang University(Medical Science), 2017, 46(3): 248-255. (in Chinese)
12	中华人民共和国卫生部. 新生儿疾病筛查技术规范(2010年版)[A/OL]. (2010-11-10)[2021-06-11]. http://www.nhc.gov.cn/cmsresources/mohfybjysqwss/cmscrsdocument/doc10798.doc Ministry of Health of the People’s Republic of China. Technical guide of newborn screening in China (2010)[A/OL]. (2010-11-10)[2021-06-11]. http://www.nhc.gov.cn/cmsresources/mohfybjysqwss/cmscrsdocument/doc10798.doc. (in Chinese)
13	LINDNERM, HOFFMANNG F, MATERND. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting[J]J Inherit Metab Dis, 2010, 33( 5): 521-526. doi: 10.1007/s10545-010-9076-8
14	TAMAOKIY, KIMURAM, HASEGAWAY, et al.A survey of Japanese patients with mitochondrial fatty acid β-oxidation and related disorders as detected from 1985 to 2000[J]Brain Dev, 2002, 24( 7): 675-680. doi: 10.1016/s0387-7604(02)00074-8
15	HANL, HANF, YEJ, et al.Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry[J]J Clin Lab Anal, 2015, 29( 2): 162-168.. doi: 10.1002/jcla.21745
16	CHIEN Y H, LEE N C, CHAO M C, et al. Fatty acid oxidation disorders in a Chinese population in Taiwan[J]. JIMD Rep, 2013, 11: 165-172
17	WANGC, CUIY, QUX. Optimization of electrotransformation (ETF) conditions in lactic acid bacteria (LAB)[J]J MicroBiol Methods, 2020, 105944. doi: 10.1016/j.mimet.2020.105944
18	胡晓明, 李　莉, 米　荣, 等. ETFDH基因复合杂合突变致新生儿多种酰基辅酶A脱氢酶缺乏症家系一例并文献复习[J]. 中华新生儿科杂志, 2018, 33(3): 205-209 HU Xiaoming, LI Li, MI Rong, et al. A family affected by multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations on ETFDH and literature review[J]. Chinese Journal of Neonato-logy, 2018, 33(3): 205-209. (in Chinese)
19	FANX, XIEB, ZOUJ, et al.Novel ETFDH mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency[J]Mol Genet Metab Rep, 2018, 15-19. doi: 10.1016/j.ymgmr.2018.05.007
20	王伟青, 宋东坡, 于春冬, 等. 多种酰基辅酶A脱氢酶缺乏症1例病例报告[J]. 中国循证儿科杂志, 2019, 14(4): 313-316 WANG Weiqing, SONG Dongpo, YU Chundong, et al. A case report of multiple acyl-CoA dehydrogenase deficiency[J].Chinese Journal of Evidence Based Pediatrics, 2019, 14(4): 313-316. (in Chinese)
21	DINGM, LIUR, QIUBOL, et al.Neonatal-onset multiple acyl-CoA dehydrogenase deficiency (MADD) in the ETFDH gene: a case report and a literature review[J/OL]Medicine, 2020, 99( 37): e21944. doi: 10.1097/MD.0000000000021944
22	VAN DER WESTHUIZENF H, SMUTSI, HONEYE, et al.A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency[J]J Neurol Sci, 2018, 121-125. doi: 10.1016/j.jns.2017.11.012
23	VAN RIJTW J, FERDINANDUSSES, GIANNOPOULOSP, et al.Prediction of disease severity in multiple acyl‐CoA dehydrogenase deficiency: a retrospective and laboratory cohort study[J]J Inherit Metab Dis, 2019, 42( 5): 878-889. doi: 10.1002/jimd.12147
24	ZHUM, ZHUX, QIX, et al.Riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency in 13 cases, and a literature review in mainland Chinese patients[J]J Hum Genet, 2014, 59( 5): 256-261. doi: 10.1038/jhg.2014.10
25	OLSENR K J, ANDRESENB S, CHRISTENSENE, et al.Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency[J]Hum Mutat, 2003, 22( 1): 12-23. doi: 10.1002/humu.10226
26	XIJ, WENB, LINJ, et al.Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency[J]J Inherit Metab Dis, 2014, 37( 3): 399-404. doi: 10.1007/s10545-013-9671-6
27	WANGZ Q, CHENX J, MURONGS X, et al.Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A[J]J Mol Med, 2011, 89( 6): 569-576. doi: 10.1007/s00109-011-0725-7
28	LANM Y, FUM H, LIUY F, et al.High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy[J]Clin Genet, 2010, 78( 6): 565-569. doi: 10.1111/j.1399-0004.2010.01421.x
29	GRüNERTS C. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency[J]Orphanet J Rare Dis, 2014, 9( 1): 117. doi: 10.1186/s13023-014-0117-5
30	ERSOYE O, RAMAD, üNAL?, et al.Glutaric aciduria type 2 presenting with acute respiratory failure in an adult[J]Respir Med Case Rep, 2015, 92-94. doi: 10.1016/j.rmcr.2015.02.009
31	FUH X, LIUX Y, WANGZ Q, et al.Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency[J]Neurol Sci, 2016, 37( 7): 1099-1105. doi: 10.1007/s10072-016-2549-2
32	VASILJEVSKIE R, SUMMERSM A, LITTLED G, et al.Lipid storage myopathies: current treatments and future directions[J]Prog Lipid Res, 2018, 1-17. doi: 10.1016/j.plipres.2018.08.001

[1]	韩连书. 新生儿遗传病基因筛查技术及相关疾病[J]. 浙江大学学报（医学版）, 2021, 50(4): 429-435.
[2]	于玥,凌诗颖,帅瑞雪,邱文娟,张惠文,梁黎黎,季文君,刘宇超,顾学范,韩连书. 720例甲基丙二酸血症MMACHC基因c.609G>A突变患者临床特征及随访分析[J]. 浙江大学学报（医学版）, 2021, 50(4): 436-443.
[3]	徐玮泽,俞凯,徐佳俊,叶菁菁,李昊旻,舒强. 先天性心脏病心音听诊筛查的人工智能技术应用现状[J]. 浙江大学学报（医学版）, 2020, 49(5): 548-555.
[4]	胡真真,杨建滨,胡凌微,赵云飞,张超,杨茹莱,黄新文. 浙江省新生儿异戊酸血症筛查及临床分析[J]. 浙江大学学报（医学版）, 2020, 49(5): 556-564.
[5]	黄淑敏,赵正言. 重症联合免疫缺陷病新生儿筛查及免疫系统重建研究进展[J]. 浙江大学学报（医学版）, 2019, 48(4): 351-357.
[6]	吴鼎文,芦斌,杨建滨,杨茹莱,黄新文,童凡,郑静,赵正言. 3-羟基异戊酰基肉碱代谢异常新生儿遗传学分析[J]. 浙江大学学报（医学版）, 2019, 48(4): 390-396.
[7]	童凡,杨茹莱,刘畅,吴鼎文,张婷,黄新文,洪芳,钱古柃,黄晓磊,周雪莲,舒强,赵正言. 新生儿酪氨酸血症筛查及基因谱分析[J]. 浙江大学学报（医学版）, 2019, 48(4): 459-464.
[8]	黄新文等. 浙江省新生儿氨基酸代谢疾病筛查及随访分析[J]. 浙江大学学报（医学版）, 2017, 46(3): 233-239.
[9]	朱晖等. 高龄孕妇外周血胎儿游离DNA产前筛查胎儿常见非整倍体的临床意义[J]. 浙江大学学报（医学版）, 2017, 46(3): 256-261.
[10]	洪芳等. 浙江省新生儿有机酸尿症筛查及随访分析[J]. 浙江大学学报（医学版）, 2017, 46(3): 240-247.
[11]	郑静等. 浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析[J]. 浙江大学学报（医学版）, 2017, 46(3): 248-255.
[12]	李恩书等. 不同氧浓度培养对体外受精-胚胎移植及子代出生缺陷的影响[J]. 浙江大学学报（医学版）, 2017, 46(3): 290-294.
[13]	毛华庆;杨茹莱;刘朝晖;徐益红;茹茵;梁建凤;赵正言. 新生儿先天性甲状腺功能低下症与出生体重及胎龄关系的研究[J]. 浙江大学学报（医学版）, 2007, 36(4): 378-381.
[14]	陈肖肖;杨茹莱;施玉华;曹莉佩;周雪莲;毛华庆;赵正言. 浙江省1999-2004年新生儿先天性甲状腺功能低下症筛查分析[J]. 浙江大学学报（医学版）, 2005, 34(4): 304-307.
[15]	赵正言;曲一平;陈黎勤;俞锡林. 浙江省726 998名新生儿苯丙酮尿症筛查分析 [J]. 浙江大学学报（医学版）, 2005, 34(2): 185-187.

Viewed

Full text

Abstract

Cited

Shared

Discussed